Loading...
•
Sep 30, 2021
SIGA Technologies Q3 2021 Earnings Report
SIGA Technologies reported a net loss and decrease in revenue compared to the same quarter last year, but anticipates significant TPOXX deliveries in Q4.
Key Takeaways
SIGA Technologies reported a challenging third quarter with a net loss of $3.1 million and total revenues of $4.8 million, a significant decrease from the $44.3 million in revenue and $24.2 million net income reported in the same period last year. However, the company anticipates delivering up to $113 million of oral TPOXX to the U.S. government in the fourth quarter. The company also repurchased 1.1 million shares for $7.1 million during the quarter.
SIGA reported a net loss of $3.1 million, or $0.04 per share, compared to a net income of $24.2 million, or $0.31 per share, in Q3 2020.
Total revenues for Q3 2021 were $4.8 million, a decrease from $44.3 million in Q3 2020.
The company expects to deliver up to approximately $113 million of oral TPOXX to the U.S. government in Q4 2021.
SIGA repurchased 1.1 million shares of its common stock for $7.1 million during the third quarter of 2021.
SIGA Technologies
SIGA Technologies
SIGA Technologies Revenue by Segment
Revenue by Segment
Product sales & supportive services Revenue
CapyFin.comResearch and development Revenue
CapyFin.com Forward Guidance
SIGA Technologies anticipates delivering up to approximately $113 million of oral TPOXX to the U.S. government in the fourth quarter of 2021.
Positive Outlook
- Delivery of up to approximately $113 million of oral TPOXX to the U.S. government in the fourth quarter of 2021.
- Strong and growing revenue base of TPOXX.
- Continuing importance in orthopox health security preparedness.
- BARDA exercised a procurement option under the 19C BARDA contract for the delivery of oral TPOXX.
- New share repurchase authorization allows for repurchasing up to $50 million of common stock.
Challenges Ahead
- COVID-19 pandemic may continue to delay the timing of international contract awards for oral TPOXX.
- The COVID-19 pandemic could result in a slower pace of product deliveries if the pandemic results in shortages or delays in the receipt by the supply chain of raw materials.
- Executive Order 14042 could have a material impact on the availability and/or timing of services provided to SIGA by certain vendors for supply chain activities and research and development activities.
- Pandemic could have an impact upon the broader macro environment or the Company’s industry.
- Company reported a net loss of $3.1 million for the third quarter.
Revenue & Expenses
Visualization of income flow from segment revenue to net income